$1.00
-0.03-2.90%
Reshape Lifesciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Reshape Lifesciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2024-05-15 | $-5.22 | $-9.28 | 43.8 % |
Q3 | 2023-11-08 | $-59.16 | $-69.60 | 15.0 % |
Q2 | 2023-08-07 | $-62.64 | $-103.82 | 39.7 % |
Q1 | 2023-05-15 | $-90.48 | $-244.18 | 62.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $2.29M | $2.51M | -8.69 % |
Q2 | 2024-08-14 | $1.97M | $2.21M | -11.1 % |
Q1 | 2024-05-15 | $1.94M | $2.10M | -7.43 % |
Q3 | 2023-11-08 | $2.15M | $2.40M | -10.2 % |
Reshape Lifesciences (RSLS) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-3.11, which missed the estimate of $0.00.
The Actual Revenue was $2.3M, which missed the estimate of $2.5M.
Browse earnings estimates, EPS, and revenue on all stocks.